Bioorthogonal chemistries for theranostics and radioconjugates
Advanced Drug Delivery Reviews · 2026-12 · 239 · 115978
DOI: 10.1016/j.addr.2026.115978 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2026-12. Verfasst von Kaiqiang Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, 119074, Singapore; Theranostics Centre of Exce…. Hauptthemen laut MEDLINE: Theranostic Nanomedicine, Radiopharmaceuticals. Die Arbeit nennt 117 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Medical Research Council, National University of Singapore.
Abstract (Originalsprache)
The integration of diagnostic imaging and targeted therapy into unified theranostic platforms represents a paradigm shift in precision medicine. Yet, clinical efficacy is often hampered by suboptimal pharmacokinetics that impair target-specific uptake and increase systemic exposure, representing a persistent obstacle to effective in vivo delivery. Bioorthogonal chemistry provides a complementary strategy to address these limitations by enabling high-fidelity chemical reactions to occur directly within the living subject. By facilitating strategies such as in vivo pretargeting and stimulus-responsive payload release, these distinct chemical tools allow for the temporal decoupling of targeting vectors from cytotoxic radioactivity, and 'click-to-clear' strategies additionally provide selective clearance of circulating radioconjugates to expand the therapeutic window. This capability for on-demand molecular assembly and activation has broadened the scope of nuclear medicine and stimulated growing interest in bioorthogonal-based interventions. This review summarizes the latest advancements in utilizing bioorthogonal chemistry for theranostics and mainly focuses on pretargeted imaging and therapy approaches as well as bioorthogonal cleavage-mediated activation. In addition, we critically examine the translational barriers and clinical prospects of implementing these advanced chemical systems in patient care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, 119074, Singapore; Theranostics Centre of Excellence (TCE), Yong Loo Lin School of Medicine, National University of…
- Center for Nuclear Medicine and Molecular Imaging, Shandong Cancer Hospital and Institute, Jinan 250117, China.
- State Key Laboratory of Vaccines for Infectious Diseases, School of Public Health, Xiamen University, Xiamen, Fujian 361102, China.
- State Key Laboratory of Vaccines for Infectious Diseases, School of Public Health, Xiamen University, Xiamen, Fujian 361102, China. Electronic address: zijing.li@xmu.edu.cn.
- Center for Nuclear Medicine and Molecular Imaging, Shandong Cancer Hospital and Institute, Jinan 250117, China. Electronic address: chen9647@gmail.com.
Förderung
- National Natural Science Foundation of China
- National Medical Research Council
- National University of Singapore
- Shandong First Medical University
Zitieren
APA
Zhang, K., Han, T., Pei, J., Zeng, F., Zhao, X., Li, Z., Chen, X., & Zhang, J. (2026). Bioorthogonal chemistries for theranostics and radioconjugates. Advanced Drug Delivery Reviews, 239, 115978. https://doi.org/10.1016/j.addr.2026.115978
Vancouver
Zhang K, Han T, Pei J, Zeng F, Zhao X, Li Z, et al. Bioorthogonal chemistries for theranostics and radioconjugates. Advanced Drug Delivery Reviews. 2026;239:115978. doi:10.1016/j.addr.2026.115978
BibTeX
@article{Zhang2026,
author = {Zhang, Kaiqiang and Han, Tianyang and Pei, Jinli and Zeng, Fantian and Zhao, Xinzhi and Li, Zijing and Chen, Xiaoyuan and Zhang, Jingjing},
title = {Bioorthogonal chemistries for theranostics and radioconjugates},
journal = {Advanced Drug Delivery Reviews},
year = {2026},
volume = {239},
pages = {115978},
doi = {10.1016/j.addr.2026.115978}
}
EUVIMED